New antibiotic-resistant gonorrhea poses severe risks to sexually active adults. Doctors warns, recommend protecting yourself ...

A new strain of gonorrhea has emerged, causing significant concern among health professionals due to its resistance to traditional treatments. This sexually ...

But few know that chlamydia, one of the most common STIs, is a major cause of infertility when left untreated. Too many ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

Metro Detroit has earned the dubious distinction of leading the country with the highest rate of sexually transmitted ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical ...

Neisseria gonorrhoeae is the bacterium responsible for gonorrhea, a common sexually transmitted infection (STI) that poses significant public health challenges worldwide. The increasing resistance ...

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...

Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.

Metro Health's mobile units provide testing and treatment for most sexually transmitted infections at no cost.